1. Home
  2. APPS vs KARD Comparison

APPS vs KARD Comparison

Compare APPS & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digital Turbine Inc.

APPS

Digital Turbine Inc.

HOLD

Current Price

$10.50

Market Cap

1.2B

Sector

Miscellaneous

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

HOLD

Current Price

$12.96

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPS
KARD
Founded
N/A
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2012
2026

Fundamental Metrics

Financial Performance
Metric
APPS
KARD
Price
$10.50
$12.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$17.00
★ $38.67
AVG Volume (30 Days)
★ 2.5M
618.2K
Earning Date
11-02-2026
11-22-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.92
N/A
EPS
★ N/A
N/A
Revenue
★ $103,569,000.00
N/A
Revenue This Year
$17.68
N/A
Revenue Next Year
$11.78
$50.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 38.55
N/A
52 Week Low
$2.74
$12.23
52 Week High
$15.34
$27.00

Technical Indicators

Market Signals
Indicator
APPS
KARD
Relative Strength Index (RSI) 49.11 36.47
Support Level $10.07 $12.23
Resistance Level $10.80 $15.93
Average True Range (ATR) 0.68 1.38
MACD -0.07 0.09
Stochastic Oscillator 54.71 18.92

Price Performance

Historical Comparison
APPS
KARD

About APPS Digital Turbine Inc.

Digital Turbine Inc is an independent mobile growth platform that levels up the landscape for advertisers, publishers, carriers, and device original equipment manufacturers. The Company offers end-to-end products and solutions leveraging proprietary technology to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. In addition, its products and solutions provide monetization opportunities for OEMs, carriers, and application (app or apps) publishers and developers.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: